Ben H. Park

Oncology

719 Thompson Ln Ste 25000
Nashville, TN 37204

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 149 publications

Liquid Biopsies for Cancer: A Translational Science Review.

Liquid Biopsies for Cancer: A Translational Science Review.

Journal: JAMA

Published: August 10, 2026

Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 Trial.

Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 Trial.

Journal: JCO oncology advances

Published: May 18, 2026

The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 10, 2026

Clonal Hematopoiesis and Cardiovascular Disease Risk After Cancer Therapy in Patients With Solid Tumors.

Clonal Hematopoiesis and Cardiovascular Disease Risk After Cancer Therapy in Patients With Solid Tumors.

Journal: JAMA oncology

Published: January 08, 2026

Distinct and convergent effects of SF3B1 mutations in human breast cancer.

Distinct and convergent effects of SF3B1 mutations in human breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 07, 2025

TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer.

TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer.

Journal: ESMO open

Published: October 07, 2025

Clonal Hematopoiesis of Indeterminate Potential After Radiation Therapy.

Clonal Hematopoiesis of Indeterminate Potential After Radiation Therapy.

Journal: International journal of radiation oncology, biology, physics

Published: July 01, 2025

Molecular Characterization of Oncogenic Gene Fusions in a Large Real-World Cohort of Solid Tumors.

Molecular Characterization of Oncogenic Gene Fusions in a Large Real-World Cohort of Solid Tumors.

Journal: Cancer research communications

Published: June 17, 2025

Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific Manner.

Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific Manner.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 01, 2025

Pan-Cancer Analyses Reveal Disparities in Tumor Genomic Profiles by Race/Ethnicity, Age, and Sex.

Pan-Cancer Analyses Reveal Disparities in Tumor Genomic Profiles by Race/Ethnicity, Age, and Sex.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: March 11, 2025

Prevalence and Associated Factors for Depression Among Patients With Sarcoma.

Prevalence and Associated Factors for Depression Among Patients With Sarcoma.

Journal: JCO oncology practice

Published: March 04, 2025

Proteomic Analysis of PTEN-Deficient Cells Reveals Src-Mediated Upregulation of EphA2 and Therapeutic Potential of Dual Inhibition.

Proteomic Analysis of PTEN-Deficient Cells Reveals Src-Mediated Upregulation of EphA2 and Therapeutic Potential of Dual Inhibition.

Journal: Molecular & cellular proteomics : MCP

Published: February 09, 2025

Showing 1-12 of 149

Last Updated: 09/26/2026